Best Evidence Yet That Lowering Blood Pressure Can Prevent Dementia

Neuroscience News logo for mobile.

Finest Proof But That Reducing Blood Stress Can Forestall Dementia

Abstract: The findings indicate a linear relationship between decrease blood strain and decrease dementia threat in adults aged 69 and older.

Supply: George Institute for International Well being

A worldwide examine of greater than 28,000 folks has offered the strongest proof to this point that decreasing blood strain later in life can cut back the danger of dementia.

Dr Ruth Peters, affiliate professor at UNSW Sydney and head of the dementia program on the George Institute’s International Mind Well being Initiative, mentioned that with out vital breakthroughs within the therapy of dementia, lowering the danger of growing the illness could be a welcome step ahead.

“Given the growing old of the inhabitants and the substantial prices of caring for folks with dementia, even a small discount might have an enormous international impression,” she mentioned.

“Our examine means that utilizing available remedies to decrease blood strain is at present one in all our ‘greatest bets’ to fight this insidious illness.”

Dementia is quickly turning into a worldwide epidemic, at present affecting roughly 50 million folks worldwide. This determine is anticipated to triple by 2050, primarily as a result of growing old of the inhabitants.

It’s at present estimated to price between 20 and 40,000 US {dollars} per particular person with the illness every year.
Dr Peters defined that whereas many trials have appeared on the well being advantages of decreasing blood strain, few have included dementia outcomes and even fewer have been placebo-controlled – thought of to offer the most effective degree of proof.
“Most trials had been stopped early as a result of vital impression of decreasing blood strain on cardiovascular occasions, which are likely to happen sooner than indicators of dementia,” she mentioned.

To take a more in-depth have a look at the connection between blood strain and dementia, the researchers analyzed 5 randomized, double-blind, placebo-controlled trials that used completely different antihypertensive remedies and adopted sufferers till the event of dementia.

A complete of 28,008 folks with a mean age of 69 and a historical past of hypertension from 20 nations had been included. In all of those research, the common follow-up was simply over 4 years.

“We discovered that therapy had a major impact in lowering the danger of dementia related to a sustained discount in blood strain on this older inhabitants,” Dr Peters mentioned.

“Our outcomes indicate a largely linear relationship between diminished blood strain and a decrease threat of dementia, no matter the kind of therapy used.”

The researchers hope the findings will assist design public well being measures to gradual the development of dementia in addition to inform therapy, the place there could also be hesitation about how far to decrease blood strain at an age. superior.

Dementia is quickly turning into a worldwide epidemic, at present affecting roughly 50 million folks worldwide. Picture is in public area

“Our examine supplies the most effective out there proof to indicate that blood strain decreasing therapy over a number of years reduces the danger of dementia, and we noticed no proof of hurt,” Dr Peters mentioned.

“However what we nonetheless do not know is whether or not additional decreasing blood strain in individuals who have already got it effectively managed or beginning therapy earlier in life would scale back the long-term threat of dementia. “, she added.

Professor Craig Anderson, director of the International Mind Well being program on the George Institute, mentioned: “This work is a vital basis for scientific trials to offer dependable estimates of the advantages and dangers of preventive remedies, and the way greatest to use them to completely different populations. ”

Funding: The authors report no focused funding. RP is funded by the Australian Nationwide Well being and Medical Analysis Middle Australian Dementia Middle for Analysis Collaboration and Neuroscience Analysis Australia; YX is funded by NHMRC Challenge Grant (APP1160373); MW and CSA are supported by analysis grants (APP1174120 and GNT1175861 respectively) from the Nationwide Well being and Medical Analysis Council (NHMRC) of Australia and, along with JC, obtain funding from an NHMRC program grant (APP1149987); MW is a marketing consultant for Amgen, Kyowa Kirin and Freeline; JC has obtained analysis grants from Servier and the NHMRC for PROGRESS and ADVANCE, and honoraria from Servier for talking at scientific conferences; CSA has obtained analysis grants from Penumbra, Takeda, Credit score and Genesis paid to its establishment.

About this information about dementia and blood strain analysis

Writer: Tina’s Wall
Supply: George Institute for International Well being
Contact: Tina Wall – George Institute for International Well being
Picture: Picture is in public area

Authentic analysis: Free entry.
“Reducing blood strain and stopping dementia: a meta-analysis of particular person affected person knowledge” by Ruth Peters et al. European journal of the guts


Reducing blood strain and stopping dementia: a meta-analysis of particular person affected person knowledge


Observational research point out U-shaped associations between blood strain (BP) and onset dementia within the aged, however randomized managed trials of BP-lowering therapy present blended outcomes on this end result in hypertensive sufferers. A pooled evaluation of particular person participant knowledge from 5 seminal, randomized, double-blind, placebo-controlled trials was undertaken to raised outline the consequences of antihypertensive therapy for the prevention of dementia.

See additionally

It shows a brain

Strategies and outcomes

Multilevel logistic regression was used to evaluate the impact of therapy on incident dementia. Impact modification was assessed for key inhabitants traits together with age, baseline systolic blood strain, gender, and presence of a earlier stroke. Mediation evaluation was used to quantify the contribution of trial medication and systolic and diastolic BP modifications to dementia threat. The full pattern included 28,008 folks recruited from 20 nations. After a median follow-up of 4.3 years, there have been 861 instances of incident dementia. Multilevel logistic regression reported an adjusted odds ratio of 0.87 (95% confidence interval: 0.75, 0.99) in favor of antihypertensive therapy lowering the danger of incident dementia with a imply lower in BP of 10/4 mmHg. Additional multinomial regression accounting for demise as a competing threat yielded comparable outcomes. There was no modification of the impact by age or intercourse. Mediation evaluation confirmed that the better drop in BP within the actively handled group was related to a better discount within the threat of dementia.


The primary single-stage meta-analysis of particular person affected person knowledge from randomized, double-blind, placebo-controlled scientific trials supplies proof supporting the advantages of antihypertensive therapy at finish of life and later in lowering the danger of dementia. Questions stay in regards to the potential for additional BP decreasing in folks with already well-controlled hypertension and antihypertensive therapy began earlier in life to scale back the long-term threat of dementia.

Classification of proof

Class I proof in favor of antihypertensive therapy lowering the danger of incident dementia in comparison with placebo.


Back to list

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *